Showing results (491-500 of 1,005) with videos related to

Sort By:
Pageof 101
Ejhaem|April 25, 2022
Erytra blood group analyser and kode technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individualsChristof Weinstock, Willy A Flegel, Kshitij Srivastava, et al.
Ejhaem|March 22, 2022
Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplantMaxime Jullien, Marianne Coste-Burel, Beatrice Clemenceau, et al.
Ejhaem|September 14, 2021
No evidence of SARS-CoV-2 transmission through transfusion of human blood products: A systematic reviewWilliam Frank Mawalla, Belinda J Njiro, George M Bwire, et al.
Ejhaem|September 14, 2021
B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome?Juliana Ochoa-Grullón, Ascensión Peña Cortijo, Kissy Guevara-Hoyer, et al.
Ejhaem|September 14, 2021
Low SARS-CoV-2 seroprevalence in a cohort of Brazilian sickle cell disease patients: Possible effects of emphasis on social isolation for a population initially considered to be at very high riskLuiza Francisco Trafane, Vitor Antonio da Costa, Adriana da Silva Santos Duarte, et al.
Ejhaem|September 2, 2025
Chemokine Receptor Profiles as Predictors of Survival and Early Progression in Follicular LymphomaAntonella Zupo, Katrin Pansy, Lukas Gaksch, et al.
Ejhaem|September 4, 2025
Late-Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T-Cell TherapyDaisuke Ikeda, Tomohiro Nawada, Takumi Kondo, et al.
Ejhaem|February 23, 2023
Phase I study of novel SYK inhibitor TAK-659 (mivavotinib) in combination with R-CHOP for front-line treatment of high-risk diffuse large B-cell lymphomaReem Karmali, Frederique St-Pierre, Shuo Ma, et al.
Ejhaem|February 23, 2023
UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell diseaseRichard J Buka, Noémi Roy, Phillip Lr Nicolson
Ejhaem|February 23, 2023
Successful combination treatment with azacitidine and venetoclax as a bridging therapy for third allogenic stem cell transplantation in a patient with 11q23/MLL-rearranged complex karyotype acute myeloid leukemiaTaro Edahiro, Hiroshi Ureshino, Ren Chishaki, et al.
Pageof 101